Efflux Limits Tumor Drug Delivery Despite Disrupted BBB

Jessica I. Griffith, Jann N. Sarkaria, William F. Elmquist

Research output: Contribution to journalShort surveypeer-review


Apparent blood–brain barrier (BBB) disruption is common in glioblastoma (GBM), but has not translated to improved drug delivery efficacy. Recently, de Gooijer et al. demonstrated that efflux transporters can have a prominent role in limiting drug delivery. These transport systems contribute to ineffective drug delivery to tumor cells in the brain.

Original languageEnglish (US)
Pages (from-to)426-428
Number of pages3
JournalTrends in Pharmacological Sciences
Issue number6
StatePublished - Jun 2021

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology


Dive into the research topics of 'Efflux Limits Tumor Drug Delivery Despite Disrupted BBB'. Together they form a unique fingerprint.

Cite this